Goldman Sachs
ANGO icon

Goldman Sachs’s AngioDynamics ANGO Stock Holding History

Goldman Sachs’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100,000
Closed -$1.9M – 7055
2014
Q4 		$1.9M Hold
100,000
– – ﹤0.01% 3894
2014
Q3 		$1.37M Sell
100,000
-71,000
-42% -$1.01M ﹤0.01% 4284
2014
Q2 		$2.79M Sell
171,000
-130,300
-43% -$1.89M ﹤0.01% 3650
2014
Q1 		$4.75M Buy
301,300
+101,300
+51% +$1.65M ﹤0.01% 3079
2013
Q4 		$3.43M Buy
+200,000
New +$3.08M ﹤0.01% 3502

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's ANGO Position: Q2 2026 in Review

Goldman Sachs increased its AngioDynamics (ANGO) stake by 22% in Q2 2026, buying an estimated $783K and bringing the position to 382,917 shares worth $4.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3880.

Goldman Sachs first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.8M in Q4 2021. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Goldman Sachs held 382,917 shares of AngioDynamics worth $4.98M as of Q2 2026.
  • Goldman Sachs bought 68,828 AngioDynamics shares in Q2 2026, an estimated $783K.
  • AngioDynamics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3880 holding.
  • Goldman Sachs first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's AngioDynamics position peaked at $12.8M in Q4 2021.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.